These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26582398)

  • 1. Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis.
    Sathyapalan T; David R; Gooderham NJ; Atkin SL
    Sci Rep; 2015 Nov; 5():16890. PubMed ID: 26582398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of serum microRNAs profile of PCOS and identification of novel non-invasive biomarkers.
    Long W; Zhao C; Ji C; Ding H; Cui Y; Guo X; Shen R; Liu J
    Cell Physiol Biochem; 2014; 33(5):1304-15. PubMed ID: 24802714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of several circulating microRNAs from a genome-wide circulating microRNA expression profile as potential biomarkers for impaired glucose metabolism in polycystic ovarian syndrome.
    Jiang L; Huang J; Chen Y; Yang Y; Li R; Li Y; Chen X; Yang D
    Endocrine; 2016 Jul; 53(1):280-90. PubMed ID: 26860517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating microRNAs in patients with polycystic ovary syndrome.
    Ding CF; Chen WQ; Zhu YT; Bo YL; Hu HM; Zheng RH
    Hum Fertil (Camb); 2015 Mar; 18(1):22-9. PubMed ID: 25268995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression profile of plasma exosomal microRNAs in women with polycystic ovary syndrome.
    Jiang X; Li J; Zhang B; Hu J; Ma J; Cui L; Chen ZJ
    Fertil Steril; 2021 Mar; 115(3):782-792. PubMed ID: 33041053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased MicroRNA Levels in Women With Polycystic Ovarian Syndrome but Without Insulin Resistance: A Pilot Prospective Study.
    Butler AE; Ramachandran V; Cunningham TK; David R; Gooderham NJ; Benurwar M; Dargham SR; Hayat S; Sathyapalan T; Najafi-Shoushtari SH; Atkin SL
    Front Endocrinol (Lausanne); 2020; 11():571357. PubMed ID: 33101204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciculating miRNA-21 as a Biomarker Predicts Polycystic Ovary Syndrome (PCOS) in Patients.
    Jiang L; Li W; Wu M; Cao S
    Clin Lab; 2015; 61(8):1009-15. PubMed ID: 26427146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulatory microRNA 23a and microRNA 23b and polycystic ovary syndrome (PCOS): the effects of body mass index and sex hormones in an Eastern Han Chinese population.
    Xiong W; Lin Y; Xu L; Tamadon A; Zou S; Tian F; Shao R; Li X; Feng Y
    J Ovarian Res; 2017 Feb; 10(1):10. PubMed ID: 28193283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA Species in Follicular Fluid Associating With Polycystic Ovary Syndrome and Related Intermediary Phenotypes.
    Sørensen AE; Wissing ML; Englund AL; Dalgaard LT
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1579-89. PubMed ID: 26771704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of miRNA - 320 expression level and its target gene endothelin-1 with the susceptibility and clinical features of polycystic ovary syndrome.
    Rashad NM; Ateya MA; Saraya YS; Elnagar WM; Helal KF; Lashin ME; Abdelrhman AA; Alil AE; Yousef MS
    J Ovarian Res; 2019 May; 12(1):39. PubMed ID: 31064393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular diagnosis of polycystic ovary syndrome in obese and non-obese women by targeted plasma miRNA profiling.
    Romero-Ruiz A; Pineda B; Ovelleiro D; Perdices-Lopez C; Torres E; Vazquez MJ; Guler I; Jiménez Á; Pineda R; Persano M; Romero-Baldonado C; Arjona JE; Lorente J; Muñoz C; Paz E; Garcia-Maceira FI; Arjona-Sánchez Á; Tena-Sempere M
    Eur J Endocrinol; 2021 Oct; 185(5):637-652. PubMed ID: 34403358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of microRNA profile in human cumulus granulosa cells: Identification of microRNAs that regulate Notch signaling and are associated with PCOS.
    Xu B; Zhang YW; Tong XH; Liu YS
    Mol Cell Endocrinol; 2015 Mar; 404():26-36. PubMed ID: 25622783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of polycystic ovary syndrome (PCOS), sex hormones, and obesity on circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 expression.
    Murri M; Insenser M; Fernández-Durán E; San-Millán JL; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1835-44. PubMed ID: 24037889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of heme oxygenase-1 with the risk of polycystic ovary syndrome in non-obese women.
    Gao H; Meng J; Xing H; Nie S; Xu M; Zhang S; Jin Y; Sun T; Huang H; Zhang H; Wang D; Liu L
    Hum Reprod; 2014 May; 29(5):1058-66. PubMed ID: 24585089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of differentially expressed microRNAs in the ovary of polycystic ovary syndrome with hyperandrogenism and insulin resistance.
    Lin L; Du T; Huang J; Huang LL; Yang DZ
    Chin Med J (Engl); 2015 Jan; 128(2):169-74. PubMed ID: 25591557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-targeted profiling of circulating microRNAs in women with polycystic ovary syndrome (PCOS): effects of obesity and sex hormones.
    Murri M; Insenser M; Fernández-Durán E; San-Millán JL; Luque-Ramírez M; Escobar-Morreale HF
    Metabolism; 2018 Sep; 86():49-60. PubMed ID: 29410349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-483-5p and miR-486-5p are down-regulated in cumulus cells of metaphase II oocytes from women with polycystic ovary syndrome.
    Shi L; Liu S; Zhao W; Shi J
    Reprod Biomed Online; 2015 Oct; 31(4):565-72. PubMed ID: 26283014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of miR-16-5p and miR-155-5p microRNAs differentially expressed in circulating leukocytes of pregnant women with polycystic ovary syndrome and gestational diabetes.
    Hocaoglu M; Demirer S; Loclar Karaalp I; Kaynak E; Attar E; Turgut A; Karateke A; Komurcu-Bayrak E
    Gynecol Endocrinol; 2021 Mar; 37(3):216-220. PubMed ID: 33148068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome.
    Choi JH; Rhee EJ; Kim KH; Woo HY; Lee WY; Sung KC
    Eur J Endocrinol; 2011 Nov; 165(5):789-96. PubMed ID: 21865408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.